Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol for Pediatric Asthma Diagnosis
NCT02877537Phase 4Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Oct 2008
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salbutamol in asthma (3 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoints: Ventilatory mechanical impedance at Day 0 and Thoracic gas volume at Day 0. Started Oct 2008; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02877537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02877537.